{"id":"W2736153605","doi":"10.1002/nau.23315","title":"Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients","year":2017,"lang":"en","type":"article","venue":"Neurourology and Urodynamics","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Astellas Pharma, Netherlands; Astellas Pharma Europe","keywords":"Solifenacin; Mirabegron; Medicine; Overactive bladder; Placebo; Urology; Combination therapy; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422723,0.0001906748,0.0006894526,0.0001644678,0.0002053526,0.00003967892,0.00007012076,0.00008358832,0.000006628537],"category_scores_gemma":[0.0002287345,0.0001405082,0.00003126269,0.00004631817,0.000389709,0.0001208218,0.00012635,0.0003052856,4.334707e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009767617,"about_ca_system_score_gemma":0.00003701505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006153691,"about_ca_topic_score_gemma":0.0005162937,"domain_scores_codex":[0.998365,0.0003665304,0.0004330129,0.000381966,0.0002354696,0.0002180274],"domain_scores_gemma":[0.9985987,0.0005386873,0.0002885743,0.0003376708,0.00013687,0.00009948449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1912338,0.001292131,0.8039258,0.0000220248,0.0002046311,0.0000593418,0.001835171,0.00002244537,0.00003988976,0.0000111021,0.000001399907,0.001352227],"study_design_scores_gemma":[0.356499,0.002100436,0.619894,0.00001798246,0.00015283,0.000008936447,0.0002111568,0.02097338,0.000005522224,0.00005669741,0.000002652909,0.00007749633],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969018,0.00009741965,0.00001655255,0.0005856128,0.00005837336,0.002168424,0.00002065256,0.00001185676,0.0001393823],"genre_scores_gemma":[0.9994064,0.0001625517,0.0001337473,0.0001266832,0.000005785176,0.00008151203,0.00004055489,0.00002085041,0.00002189461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1840319,"threshold_uncertainty_score":0.5729759,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04653445807542036,"score_gpt":0.3530978250677579,"score_spread":0.3065633669923375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}